Metraipolis › archive › dc_0cc4fa7075e7

BAFF/APRIL expression-guided telitacicept therapy demonstrates superior efficacy in systemic lupus erythematosus patients: a real-world comparative study — Europe PMC PMID:40917862

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40917862
DOI
10.3389/fmed.2025.1608085
License (as archived)
solo-consultazione
Archived
2026-11-10T10:49:42.187Z
SHA-256 of the archived text
8451ae571f6713e5ee36ef6206187c0cd1e7053ea09059508fed28f298334247
Stable URL of this page
https://metraipolis.com/documento/dc_0cc4fa7075e7

How to cite

BAFF/APRIL expression-guided telitacicept therapy demonstrates superior efficacy in systemic lupus erythematosus patients: a real-world comparative study — Europe PMC PMID:40917862 — Europe PMC (en), https://europepmc.org/article/MED/40917862 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0cc4fa7075e7 (Metraipolis archive dc_0cc4fa7075e7, sha256 8451ae571f6713e5ee36ef6206187c0cd1e7053ea09059508fed28f298334247)
BibTeX
@misc{dc0cc4fa7075e7,
  title = {BAFF/APRIL expression-guided telitacicept therapy demonstrates superior efficacy in systemic lupus erythematosus patients: a real-world comparative study — Europe PMC PMID:40917862},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40917862},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0cc4fa7075e7; sha256 8451ae571f6713e5ee36ef6206187c0cd1e7053ea09059508fed28f298334247},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40917862. Agents can read the archived copy with the MCP tool read_document.